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This review evaluates the viability of delayed reward discounting (DRD), an index of how
much an individual devalues a future reward based on its delay in time, for genetically-
informed drug abuse prevention. A review of the literature suggests that impulsive DRD
is robustly associated with drug addiction and meets most of the criteria for being an
endophenotype, albeit with mixed findings for specific molecular genetic influences.
Several modes of experimental manipulation have been demonstrated to reduce DRD
acutely. These include behavioral strategies, such as mindfulness, reward bundling,
and episodic future thinking; pharmacological interventions, including noradrenergic
agonists, adrenergic agonists, and multiple monoamine agonists; and neuromodulatory
interventions, such as transcranial magnetic stimulation and transcranial direct current
stimulation. However, the generalization of these interventions to positive clinical
outcomes remains unclear and no studies to date have examined interventions on DRD
in the context of prevention. Collectively, these findings suggest it would be premature
to target DRD for genetically-informed prevention. Indeed, given the evidence of
environmental contributions to impulsive DRD, whether genetically-informed secondary
prevention would ever be warranted is debatable. Progress in identifying polymorphisms
associated with DRD profiles could further clarify the underlying biological systems for
pharmacological and neuromodulatory interventions, and, as a qualitatively different risk
factor from existing prevention programs, impulsive DRD is worthy of investigation at a
more general level as a novel and promising drug abuse prevention target.
Keywords: substance use disorders, drug abuse, addiction, behavior economics, delayed reward discounting,
behavioral economics, intertemporal choice
Introduction
Excessive use of addictive drugs is both widespread and onerous, contributing to to approximately
22% of deaths and costing more than $500 billion annually in the United States (Mokdad et al., 2004;
Uhl and Grow, 2004). A high priority for reducing the burden of addictive disorders is to translate
knowledge of the underlying risk factors for addiction into prevention and early intervention
approaches. Numerous factors influence the probability of initiation and progression of drug use,
Frontiers in Psychology | www.frontiersin.org September 2015 | Volume 6 | Article 11041
Gray and MacKillop Delayed reward discounting, genetics, and prevention
but one well established domain is genetic variation, which
is estimated to contribute approximately half of the liability
for developing drug addiction (Goldman et al., 2005; Agrawal
and Lynskey, 2008). From a theoretical perspective, aligning
prevention efforts to address genetic risks has very high potential,
as it would focus on important etiological variables that are not
currently considered from a prevention perspective and would
seek to assist individuals who are constitutionally at elevated
risk. It would be a form of personalized medicine, but at
the level of prevention. Ideally, genetically-informed prevention
programming would go one step further and would target the
specific ways that genetic variation give rise to drug abuse
risk, the biopsychosocial mechanisms of risk. By permitting
very early risk identification and the delivery of maximally
relevant prevention programming, prevention strategies that are
specifically tailored to genetically-influenced risk mechanisms
would have the potential to have a major impact.
At a behavioral level, an increasingly well-established risk
factor for drug abuse is impulsive decision making, specifically,
the propensity to select an immediate reward at the expense
of greater future rewards. This form of impulsivity is typically
referred to as delayed reward discounting (DRD) or capacity
to delay gratification, and has also been increasingly linked
to genetic influences. The link to genetics in turn suggests
that impulsive DRD may be a viable candidate for genetically-
informed prevention. In practice, what this means is that
individuals with genetic profiles associated with more impulsive
DRD would pre-emptively receive programming to reduce
preferences for immediate gratification and, ultimately, to reduce
the probability of subsequent drug abuse. Thiswould be a radically
different strategy from current prevention efforts and could be
very powerful, both for preventing drug abuse and a number of
adverse health outcomes. However, it is also lofty prospect that is
highly contingent on a number of relationships being empirically
robust.
The goal of the current review is to concretely evaluate the
existing literature on the prospects of DRD as a genetically-
informed prevention target. The review has four goals: (1) to
introduce DRD as a behavioral characteristic and review its
association with drug abuse; (2) to review the evidence suggesting
DRD is an endophenotype (i.e., a genetically-influenced
mechanism of risk for addictive disorders); (3) to review
candidate intervention approaches for reducing impulsive DRD;
(4) to critique the extent to which the preceding sections “connect
the dots” to make an compelling argument for such an approach.
Methodology
To conduct our review, we examined the published literature
using the Public Library of Medicine (PubMed) and PsychINFO
databases. Specifically, we examined individual empirical articles
and reviews that addressed DRD in the context of drug abuse,
behavioral genetics, and manipulations or interventions that
reduce impulsive DRD. The review included studies on DRD
in both humans and non-human animals, but, given that
DRD is generally independent of other measures of impulsivity
(e.g., MacKillop et al., 2014), we did not include studies of
FIGURE 1 | Prototypic hyperbolic delayed reward discounting curves
reflecting the discounted subjective value of $100 delayed from 1 day
to 1 year The curves reflect the points at which the smaller immediate
reward is equal in value to the $100 delayed reward. For example, at a
delay of 100 days, $100 has lost 50% of its nominal value for the low
impulsivity profile and 90% of its nominal value for the high impulsivity
profile. Figure from MacKillop (2013).
other domains. Articles in the two major domains of the study
(genetic influences on DRD and strategies for reducing DRD)
were critiqued in detail and the accompanying cited works were
used to identify other potentially relevant studies. However, a
specific search protocol using a discrete set of search terms was
not implemented, meaning that this article is more appropriately
considered a critical review of the literature, but not a formal
systematic review (e.g., Khan et al., 2003).
Delayed Reward Discounting
and Drug Abuse
Delayed reward discounting is typically assessed using decision-
making tasks posing choices between a smaller monetary reward
that is immediately available and a larger delayed reward after
an intervening delay. By varying the reward amounts and the
delay length, an overall characterization of temporal discounting
rates can be generated. Figure 1 provides illustrative discounting
temporal discounting curves for $100 available in the future
versus smaller amounts available in the present. Quantitative
indices of discounting are typically generated either using non-
linear regression to derive an individual’s temporal discounting
function (i.e., k) or generating the area under the curve
(AUC; Myerson et al., 2001). The k index reflects the slope
of the hyperbolic discounting function and AUC reflects the
overall volume of the discounting curve. The two are strongly
inversely correlated; steeper discounting curves have high k values
and low AUCs. Both indices have their own advantages and
disadvantages, with the primary difference being that k makes
implicit assumptions about the hyperbolic formof the discounting
function, whereas AUC is theory-free and does not make
assumptions about the specific form of the curve (Myerson et al.,
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2001). Although often administered for hypothetical outcomes, a
number of studies suggest that individuals respond similarly on
versions of the task in which they are provided with an actual
monetary reward based on their responses (Johnson and Bickel,
2002; Madden et al., 2003; Bickel et al., 2009; Lawyer et al.,
2011). Furthermore, studies have demonstrated robust test-retest
reliability, with comparable stability to personality traits (Beck
and Triplett, 2009; Kirby, 2009; Odum, 2011). Money is the most
commonly used commodity and has a number of advantages
(e.g., generality of relevance, meaningfulness of discrete units),
but other commodities, including addictive drugs, can be assessed
using DRD paradigms. Indeed, some of the earliest work in this
area used the now famous “marshmallow test” in which children
choose between one marshmallow immediately available after the
experimenter leaves the room or two marshmallows if they wait
for the experimenter to return (Metcalfe and Mischel, 1999).
Individuals who strongly prefer immediate over delayed
rewards of larger value are said to exhibit impulsive discounting of
delayed rewards. Impulsive DRD is associated with earlier age of
addiction onset (Domet al., 2006), dependence onmultiple classes
of drugs (e.g., tobacco, alcohol, cocaine; MacKillop et al., 2011),
and treatment response (MacKillop and Kahler, 2009; Sheffer
et al., 2014). Furthermore, a meta-analysis synthesized previous
literature on DRD in relation to addictive behavior by comparing
levels of DRD between criterion (addicted) groups and control
groups (MacKillop et al., 2011), finding consistent evidence of
significantly more impulsive DRD in criterion groups, with a
medium effect size across studies (d = 0.58).
Although debate has arisen regarding the extent to which DRD
is a cause or consequence of addiction (or whether they are both
influenced by a third variable), there is increasing evidence that
DRD preferences at least partially predates the development of
addiction. Two retrospective studies have identified that more
impulsiveDRDpredicts earlier onset of alcohol use (Kollins, 2003)
and alcohol use disorder symptoms (Dom et al., 2006). Several
subsequent studies have found a link between more impulsive
DRD in adolescents and increased substance use and/or misuse
over time (Audrain-McGovern et al., 2009; Fernie et al., 2013;
Khurana et al., 2013; Kim-Spoon et al., 2014). However, one recent
study did not find a consistent connection between DRD and
subsequent substance use (Isen et al., 2014). Notably, the null
results in this studymay be partially attributable to their utilization
of an externalizing latent factor that included a broader spectrum
of externalizing behaviors than simply drug use and misuse (e.g.,
disinhibited, delinquent, and aggressive behavior). In sum,DRD is
a well-validated behavioral measure of impulsivity, is consistently
associated with addictive behavior, and is an etiological risk factor,
predating alcohol and tobacco use and misuse.
Delayed Reward Discounting as a Drug
Abuse Endophenotype
Although approximately 50% of all variance in addictive
disorders is genetic risk (Goldman et al., 2005; Agrawal and
Lynskey, 2008), little variance has been consistently accounted
for by molecular genetic studies. In fact, candidate gene studies
(assessing associations with a small number of variants in a
limited number of genes) and genome-wide association studies
(assessing associations with hundreds of thousands of variants
across the genome) have both identified variants which are
inconsistently replicated and exhibit small effect sizes (Goldman
et al., 2005; Treutlein and Rietschel, 2011). This gap between
high levels of heritability and specific variants of inconsistent
and small effects is referred to as the “missing heritability
problem” (Turkheimer, 2011). Several potential factors contribute
to this issue, but perhaps two are most notable: (1) addictive
disorders are highly polythetic (i.e., hundreds of combinations
of symptoms can produce the same diagnosis); and (2) addictive
disorders are “too far” from the genes, meaning that the
proximal consequences of genetic variation may be only distantly
related to the proximal risk factors for drug abuse. As a
result of these obstacles, an endophenotype approach has been
proposed, shifting the focus to narrower phenotypes that are
putatively determined by a more limited number of genes
and are more specifically associated with the disorder of
focus. Endophenotypes are also intended to be mechanistically
informative about the nature of genetic influences. Given both
links to genetics and mechanisms of risk, endophenotypes are the
natural intervention targets in the context of genetically-informed
prevention.
Importantly, a number of criteria have been increasingly
accepted as defining an endophenotype. These comprise evidence
of the following: (1) association with the illness, meaning a
link with the condition of interest; (2) heritability, meaning
evidence that the characteristic is influenced by genetics; (3) state
independence, meaning the characteristic is present when the
disease is not (and is not simply a symptom of the condition);
(4) present in non-affected family members at higher rates than
the general population, further indicating its genetic basis; and
(5) co-segregation with the psychiatric illness in families, further
indicating association (Gottesman and Gould, 2003).
For DRD, the first of these criteria was addressed above,
in the links between the behavioral characteristic of DRD and
drug abuse. Shifting to the heritability of DRD, there is robust
evidence from animal and human studies. Animal studies are
particularly useful for assessing heritability of traits because
they allow researchers to control all aspects of the environment.
The reduction in environmental variability enables isolation of
the effects of genetic variability. In animal studies, researchers
typically compare behaviors across inbred strains that are isogenic
(i.e., entirely or nearly genetically identical; Falconer et al., 1996).
In the first rodent study of DRD heritability, approximately 16%
of variability in DRD rates was attributable to between-strain
differences in mice (Isles et al., 2004). Studies of Lewis and
Fischer rodents reared in identical environments also identified
systematic differences in discounting across strains that are
attributable to genetic differences (Anderson and Woolverton,
2005; Madden et al., 2008; Stein et al., 2012). Finally, in a recent
study, the estimated heritability across eight strains was between
43 and 66% (Richards et al., 2013). Overall, these studies largely
found robust differences in DRD across rodent strain, suggesting
substantial heritability of DRD.
To date, four human studies have assessed the heritability of
delay discounting and all four identified evidence of heritability.
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Early adolescent twins were found to have genetic influences
on DRD at ages 12 (30%) and 14 (51%, Anokhin et al., 2011).
Additionally, in a sample of 17-year-old twins, strong evidence of
heritability was found in two different DRD phenotypes (47–51%,
Isen et al., 2014; Sparks et al., 2014). Most recently, Anokhin et al.
(2015) assessed DRD in a sample of twins and found significant
heritability of both DRD indices (AUC: 46 and 62%; k: 35 and
55% at age 16 and 18 respectively). The trend of increasing genetic
influence in later adolescence is likely attributable to ongoing
adolescent brain maturation of prefrontal regions implicated
in intertemporal choice (Carter et al., 2010; Steinberg, 2010;
Peters and Büchel, 2011; Luo et al., 2012). Taken together, both
animal and human studies suggest that DRD is heritable and
possesses similar rates of heritability as addiction phenotypes
(i.e.,50%).
In the domain of family history, rodent studies support
the presence of elevated levels of DRD in non-affected family
members (as compared to the general population). Specifically,
three studies to date of alcohol-naïve rodents selectively bred
for high- or low-alcohol preference, found that high-alcohol
preferring subjects exhibited an increased rate of DRD of sucrose
rewards (Wilhelm and Mitchell, 2008; Oberlin and Grahame,
2009; Perkel et al., 2015). Notably, one study did not find a
difference in DRD of sucrose rewards between high- and low-
alcohol preferring rodents (Wilhelm et al., 2007). Nonetheless, the
majority of evidence suggests that heritability for alcohol abuse
susceptibility overlaps with heritability for DRD preference, and
that in subjects susceptible to alcohol abuse, impulsive DRD is
present prior to alcohol exposure.
While human research has been mixed regarding the presence
of DRD at elevated rates in non-affected family members, earlier
studies suffered from significant methodological issues (most
notably, small sample size; e.g., Crean et al., 2002; Petry et al.,
2002; Herting et al., 2010). A more recent highly-powered study
found that in 298 healthy young adults (age M = 23), those with
a family history positive for alcohol or other drug use disorders
had higher rates of DRD (Acheson et al., 2011). Furthermore,
the study found that impulsive DRD was significantly associated
with having more parents and grandparents with alcohol and
drug use disorders. Similarly, Dougherty et al. (2014) found
that in 386 non-affected youth (ages 10–12), those with family
histories of alcohol or other drug use disorders had higher
rates of DRD. These findings suggest that in studies with
adequate power and a thorough assessment of family history of
substance use disorders, there is evidence that non-affected family
members of individuals with substance use disorders possess
higher rates of DRD than the general population. Similarly, this
body of research suggests that given the overlap in heritability
of drug abuse and impulsive DRD, there is likely an overlap
of specific genetic loci conferring risk for drug abuse and for
DRD.
Relatively recent efforts have been made to determine the
molecular genetic basis of DRD, primarily within dopaminergic
genes. Currently, findings primarily suggest the involvement
of the single nucleotide polymorphisms (SNPs) from COMT
(rs4680) and ANKK1 (rs1800497), and the exon 3 variable
number of tandem repeats (VNTR) polymorphism in DRD4,
genes which are all implicated in dopamine neurotransmission
(Boettiger et al., 2007; Eisenberg et al., 2007; Paloyelis et al.,
2010; Gianotti et al., 2012; Smith and Boettiger, 2012; Gray
and MacKillop, 2014). Regarding rs4680, four studies found an
association between possession of the G allele and impulsive
DRD in adults (Boettiger et al., 2007; Gianotti et al., 2012;
Smith and Boettiger, 2012; MacKillop et al., in press), one
found an association of A/A with impulsive DRD in young
adults (Paloyelis et al., 2010), and another found no association
(Gray and MacKillop, 2014). The A/A genotype of rs4680
is associated with a reduction in levels of catechol-O-methyl
transferase enzymatic activity (an enzyme implicated in dopamine
catabolism), which leads to higher levels of dopamine primarily
in the prefrontal cortex (Weinshilboum et al., 1999; Chen
et al., 2004; Tunbridge et al., 2004). Gianotti et al. (2012)
found that reduced activity in the left dorsal prefrontal cortex
(dPFC) during a resting state paradigm mediates the effect
of the G allele on impulsive DRD (also see Boettiger et al.,
2007). This suggests that the G allele of rs4680 reduces baseline
dPFC engagement via reduced dopamine availability, leading
to more impulsive decision making. The dPFC does indeed
appear to be strongly implicated in impulsive decision making
as it is known to impact self-control processes (Gianotti et al.,
2009; Knoch et al., 2010) and the dorsolateral prefrontal
cortex (dlPFC) has been shown to affect DRD rates when
stimulated transcranially (discussed below). Future studies with
large healthy populations are required to verify which genotype
is of greatest risk and examine moderators (e.g., age effects),
as one recent study’s findings suggest a U-shape curve between
dopamine levels and DRD performance (i.e., too much or too
little dopamine yields impulsive DRD; Smith and Boettiger,
2012). Nonetheless, current research supports a relationship
between COMT (rs4680) and DRD rates via dPFC dopamine
levels.
The T allele of rs1800497 has been associated with DRD
in two studies (Eisenberg et al., 2007; MacKillop et al., in
press), and not associated in two others (Kawamura et al., 2013;
Gray and MacKillop, 2014). However, considerable heterogeneity
in sample demographics (e.g., healthy college students, weekly
gamblers, healthy adults) and sample sizes (between 91 and
195 participants) may explain the mixed findings. The role
of the rs1800497 SNP is less well understood because it is
technically in the ANKK1 gene, near the DRD2 gene. However,
rs1800497 is in high linkage disequilibrium with SNPs from
multiple genes in this region (NCAM1-TTC12-ANKK1-DRD2,
Mota et al., 2012) and is associated with dopamine D2 receptor
density (Pohjalainen et al., 1998; Jönsson et al., 1999; Savitz
et al., 2013). Regardless of the specific mechanism of influence
of rs1800497, its association with dopamine availability and with
multiple addictive genotype influences (for a review see Ma et al.,
2014) suggests it should be investigated further in relation to DRD
rates.
DRD4 VNTR influences intracellular levels of cyclic adenosine
monophosphate to primarily impact dopamine response in the
prefrontal cortex, however, the specific downstream biochemical
impact of different variants of DRD4 VNTR remains relatively
unclear (Oak et al., 2000) and recent studies have examined
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the role of rare variants rather than length of repeats (e.g.,
Tovo-Rodrigues et al., 2012; Michealraj et al., 2014). DRD4
VNTR and DRD has been explored in several studies, with
mixed findings, and appears to have a more context dependent
relationship with DRD rates. For example, one study found
the combination of the long form of DRD4 VNTR and
the T allele of rs1800497 to be associated with significantly
higher DRD rates (Eisenberg et al., 2007), and a second
study found increased DRD rates in low socioeconomic status
(SES) long form carriers versus decreased DRD rates in mid-
to-high SES long form carriers (Sweitzer et al., 2013). In
addition, studies have reported a direct negative relationship
between the long from and decreased DRD rates (Gray and
MacKillop, 2014) and no direct association (Eisenberg et al.,
2007; Garcia et al., 2010; Paloyelis et al., 2010; Sweitzer et al.,
2013). However, the existing studies have varied widely in
sample composition (e.g., healthy college students, adolescents
with attention deficit hyperactivity disorder [ADHD]) and size
(ranging from 68 to 546). It will be important for future
studies to continue to explore the potential of DRD4 VNTR
as a differential susceptibility gene (see Bakermans-Kranenburg
and van Ijzendoorn, 2011) in order to determine whether the
relationship between DRD and polymorphisms of varying length
or rarity is contingent upon other genes or environmental
stressors.
Despite some promising findings regarding the role of
COMT, DRD2, and DRD4, the associations require consistent
replication and the effect sizes have been relatively small.
Nonetheless, current empirical findings and theory suggest a
central involvement of dopamine functioning as well as possible
interactions among serotonin and dopamine systems on DRD
performance (Winstanley et al., 2005; Simon et al., 2013).
Greater exploration of other systems related to reward processing
as well as genome-wide association studies are a priority for
future research. Identification of robust genetic correlates of
DRD would provide insights into the neurobiological causes of
variation, identifying targets for possible pharmacological and
neuromodulatory interventions.
Taken together, DRD is relatively well supported as
an endophenotype for addictive disorders, although the
identification of specific polymorphisms responsible for variation
is nascent. The initial molecular genetic studies suggest that
dopamine transmission plays an important role in DRD, yet
in almost all cases, the candidate loci were the ‘usual suspects’
(i.e., loci tested most frequently for associations with addictive
behavior and other externalizing psychopathology). Future work
that establishes the robustness of these findings and expands the
genomic perspective will be essential.
Interventions Targeting Delayed Reward
Discounting
Several experimental manipulations have been examined for
reducing high rates of DRD, and can be broadly classified
into three domains: behavioral interventions, pharmacological
interventions, and neuromodulatory manipulations using
transcranial stimulation of specific brain regions.
Behavioral Interventions
The earliest research exploring the link between distraction and
DRD was conducted on preschool age children (3–5 years old)
who underwent the aforementioned marshmallow test. In this
early work, when encouraged to think of other things or play
with toys, the children more frequently waited longer for the
delayed reward (Mischel and Ebbesen, 1970; Mischel et al., 1972).
Similar findings have been identified in animal studies (Grosch
and Neuringer, 1981; Evans and Beran, 2007). This is thought
to operate similarly to distraction manipulations that lead to
more effective resistance to food or drug cravings in susceptible
individuals (e.g., Versland and Rosenberg, 2007; Van Dillen et al.,
2013; Murphy andMacKillop, 2014). However, it remains unclear
whether distraction techniques can offer long-term (rather than
merely temporary) disruption of immediate reward pursuit (see
Ashe et al., 2015).
The converse of distraction-based techniques is a mindfulness
approachwhich seeks to encourage non-judgmental and objective
monitoring of one’s own thoughts and behaviors in an effort
make well considered, unimpulsive decisions (Marlatt, 2002).
For example, one study employed a brief 60–90 min training
based on Acceptance and Commitment Therapy (Hayes et al.,
2011; Morrison et al., 2014). In this training session, subjects
discussed internal barriers to healthy decision making with a
therapist and engaged in several exercises designed to aid the
participant in observing their emotions and learning to act on
values rather than feelings. Participants who were engaged in
this training procedure exhibited decreases in DRD, whereas
waitlist controls did not. Brief mindfulness-based interventions
have been adapted for obese individuals and have shown efficacy
for reducing DRD of food items (Hendrickson and Rasmussen,
2013). In a similar spirit of priming mindfulness, Berry et al.
(2014) found that preemptive and concurrent visual exposure
to natural environments (e.g., mountains), led to approximately
a 50% reduction in DRD compared to decisions made during
exposure to built environments (e.g., buildings) and control
environments (e.g., triangles). All of the work in this area has
focused on acute outcomes and it will be important for future
studies to explore longitudinally how mindfulness training may
influence long-term decision making patterns.
Beyond distraction and mindfulness, a wide variety of other
behavioral techniques have been applied to reduce impulsive
discounting. For example, a small number of early studies
employed a fading procedure with pigeons that gradually
increased the delay between the small reinforcer and the larger
delayed reinforcer, which yielded an increased selection of the
delayed reward (Mazur and Logue, 1978; Logue et al., 1984).
Similar studies have been conducted primarily in children with
conditions associated with impulsivity (e.g., mental retardation,
autism, ADHD) and have found reductions in DRD (Schweitzer
and Sulzer-Azaroff, 1988; Dixon et al., 1998; Fisher et al., 2000).
In the context of these experiments, the participants were offered
a small immediate reinforcer or a large reinforcer that was
contingent on engagement in a target behavior (e.g., staying
seated) for a required duration. The duration for performing the
target behavior was gradually increased overtime and the children
typically showed increasing ability to maintain this behavior for
Frontiers in Psychology | www.frontiersin.org September 2015 | Volume 6 | Article 11045
Gray and MacKillop Delayed reward discounting, genetics, and prevention
extended periods of time in order to obtain the larger reinforcer.
However, sample sizes ranged from 3 to 6 participants and the
applicability of this technique to healthy adolescents (a typical
target sample for drug abuse prevention) or substance using adults
is relatively low.
Another method of reorienting individuals toward larger
delayed rewards is “reward bundling,” or grouping a series of
DRD choices into a single decision. For example, for the “reward
bundling” condition, one recent study informed participants that
if they choose a smaller sooner reward then they will receive that
reward every 2weeks after that for 6–10weeks, and if they choose a
larger delayed reward in 10 days then they will receive that reward
every 2weeks after that for 6–10weeks (Hofmeyr et al., 2011). This
makes theoretical sense, as orienting individuals to considering
a series of consequences of a pattern of decision making (as
opposed to a consequence derived from a single choice) may
increase their consideration of avoiding a sum of reduced rewards
by choosing to favor larger greater rewards. For example, if the
choice to get intoxicated now at the cost of feeling good tomorrow
were to entail commitment to this same choice every day for the
next week, the value of the larger delayed reward relative to the
smaller sooner reward would presumably increase (Monterosso
and Ainslie, 2007). Bundling has been supported empirically by
several laboratory studies involving animals and humans (Kirby
and Guastello, 2001; Ainslie and Monterosso, 2003; Hofmeyr
et al., 2011; Stein et al., 2013). The most recent human study,
conducted by Hofmeyr et al. (2011), found that smokers, but not
non-smokers, were particularly susceptible to the reward bundling
manipulation. This suggests that those who are more susceptible
to addictive behavior may be in greater need of and more
responsive to interventions that challenge them to consider the
long-term aggregation of rewards. Relatedly, a study found that in
cocaine and/or alcohol outpatient substance users, an intervention
comprised of individual counselor-facilitated training in monthly
budgeting, which focused on long term goals and limited short-
term spending, led to a decrease in both DRD and cocaine use
(Black and Rosen, 2010).
Another strategy for modifying discounting is episodic future
thinking, which is a method of increasing future orientation
by prompting individuals with autobiographical, emotional, and
circumstantial details that are expected to occur at specified
delays in the future (Atance and O’Neill, 2001). For example
in two fMRI experiments, Peters and Büchel (2010) found
that when delays were paired with events the subjects were
likely to engage in during that time (e.g., “20€ now or 35€ in
45 days (vacation Paris)”), subjects were more likely to choose
the delayed rewards than when rewards were not presented
with these tags. This finding has been replicated in three
additional studies (Benoit et al., 2011; Daniel et al., 2013a,b).
Most recently, a study found that episodic future thinking
is not dependent on positive affect induction for its effects
rather, even neutral-valenced events shift time perspective to
reduce DRD (Lin and Epstein, 2014). Using a conceptually
similar strategy, one investigation conducted four studies utilizing
virtual reality to display computerized renderings of participants’
future selves, and in all cases they found that those who
interacted with their virtual future selves had reduced DRD
(Hershfield et al., 2011). This represents a promising method for
engaging individuals in greater imagination of their future in
order to reduce DRD.
From a more purely cognitive standpoint, a phenomenon that
has been demonstrated in several studies is framing effects, or the
tendency of DRD to fluctuate in relation to the specific wording of
the delay. Read et al. (2005) first demonstrated that when delays
are framed as calendar dates (e.g., on December 5), discount rates
tend to decrease and the shape of the discount function becomes
more linear (less hyperbolic). Other studies have had similar
findings (LeBoeuf, 2006; Klapproth, 2012; DeHart and Odum,
2015). Notably, other variables involved in question framing
have been shown to either decrease DRD, such as presenting
participants with an explicit zero paired with the options (e.g.,
“[A] $5.00 today and $0 in 26 days OR [B] $0 today and $6.20
in 26 days”; Magen et al., 2008). A common element across all
of these formats is that they seem to increase the salience of
the delay by framing the specific date (possibly increasing the
perceived likelihood of actually receiving the reward; see Patak
and Reynolds, 2007), increasing attention to the notion that
they will receive “$0” at the delay if they select the immediate
reward.
Finally, strengthening the elementary cognitive processes that
subserve DRD decision making represents a further strategy
for reducing this form of impulsivity. Two studies have been
conducted to explore the extent to which working memory
training can improve overall executive functioning capabilities
as a way to decrease DRD and improve overall decision
making capabilities. The first study randomized a small number
of individuals (N = 27) into a training condition and a
matched control condition (Bickel et al., 2011). The working
memory training used a computer program consisting of
several challenges (e.g., recalling a sequence of digits forward
or backward) administered 4–15 times over the course of
approximately 25 days. In the control condition, participants
were exposed to the same set of stimuli, but were provided
with the answers so that they did not need to engage their
working memory. The study found that the working memory
training group significantly decreased discounting rates by
approximately 50%, whereas the control group exhibited no
significant reductions in DRD. A recent study did not replicate
the connection between working memory training and reduced
DRD in a rodent model (Renda et al., 2015), although major
methodological differences were present (e.g., species, type of
task, prior substance use). Ameliorating delay discounting via
working memory is at an early stage but has considerable
promise.
Pharmacological Interventions
Several studies have tested the efficacy of dopamine (DA) agonists
(e.g., amphetamine) and DA-norepinephrine (NE) agonists (e.g.,
methylphenidate) for reducing DRD. Frequently prescribed to
individuals with ADHD, amphetamine and methylphenidate
are thought to increase executive functioning capacity by
facilitating transmission of catecholamines in critical regions
(Bidwell et al., 2011). Studies have found that both amphetamine
and methylphenidate typically reduce DRD in rat models
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(Cardinal et al., 2000; Adriani et al., 2004; van Gaalen et al.,
2006; Bizot et al., 2011), however, null or even opposite effects
have occasionally been detected when varying methodology (e.g.,
rearing environments, signaled or unsignaled rewards; Cardinal
et al., 2000; Perry et al., 2008). Of the human studies that
have been conducted, one found that amphetamine decreased
DRD in healthy adults (de Wit et al., 2002), and the others
found that methylphenidate decreased DRD in a sample of
adults with a criminal background (Pietras et al., 2003) and in
a sample of children with ADHD (Shiels et al., 2009). Despite
the promise of these human studies, the therapeutic use of
these substances in reducing DRD must be balanced with their
high abuse potential in individuals without ADHD (Kollins,
2007).
Additional compounds have been examined for efficacy in
reducing DRD, including compounds with less direct and
concentrated effects on DA availability, such as NE agonists
(e.g., atomoxetine), adrenergic agonists (e.g., guanfacine), and
multiple monoamine agonists (e.g., modafinil; Wilens, 2006).
These substances are of particular interest because they uniformly
exhibit minimal abuse potential (Malcolm et al., 2002; Muir
and Perry, 2010; Upadhyaya et al., 2013). Among these three
compounds, atomoxetine has been studied most extensively, but
only in rodent models to date. Early research by Robinson et al.
(2008) found that atomoxetine significantly decreased several
forms of impulsivity, including DRD. Similarly, Bizot et al. (2011)
found that subjects given atomoxetine were more likely to select
the large but delayed reward. However, other studies have found
atomoxetine increased DRD in healthy rodents (Broos et al.,
2012), or had no effect on DRD in healthy (Baarendse and
Vanderschuren, 2012), spontaneously hypertensive (an animal
model for ADHD; Turner et al., 2013), and cocaine-withdrawing
rodents (Broos et al., 2014). In the latter study, despite no
changes in DRD, the rodents were less likely to readminister
cocaine at 1 and 10 days (Broos et al., 2014). Finally, one study
found that chronic atomoxetine treatment during adolescence
(but not acute atomoxetine in adulthood) led to a stable decrease
in DRD when tested in adulthood, suggesting lasting effects
of the atomoxetine in the orbitofrontal cortex (Sun et al.,
2012).
Early studies testing effects of guanfacine and modafinil
on DRD are promising. One study found that intramuscular
guanfacine reducedDRD in rhesusmonkeys (Kimet al., 2012) and
a second found dose-dependent reduction in DRD in rats when
guanfacine was administered locally in the ventral hippocampus
(Abela and Chudasama, 2014). In a fMRI study on humans,
modafinil was found to decrease DRD in alcohol dependent
participants, but yielded no change in healthy control subjects,
suggesting that modafinil normalizes DRD decision making in
alcohol dependent patients (Schmaal et al., 2014). Moreover,
reductions in DRD were accompanied by an enhanced functional
connectivity between the superior frontal gyrus and ventral
striatum, suggesting more prefrontal control over these choices.
It will be important for future studies to continue to examine the
effects of these medications on DRD, particularly in humans with
and without high levels of DRD, to establish the consistent and
stable effects.
Neuromodulatory Manipulations
Recent efforts have been made to explore the impact of
human non-invasive transcranial brain stimulation on DRD,
both through magnetic and direct electrical current stimulation.
Transcranial magnetic stimulation (TMS) operates by passing
electricity through a coil placed near the region of focus. The
resulting magnetic field can be used to temporarily modulate
brain activity in nearby regions. One group assessed the effect
of dlPFC interruption during a DRD task as well as a single
item valuation task (i.e., participants rated the attractiveness of
12 single-options taken from the DRD choice set; Figner et al.,
2010). They found that left (but not right) dlPFC inhibition
increased impulsive responding on the DRD task, but neither
region impacted item valuation on the single item valuation
task. This suggests that the left dlPFC is critical to self-control
(inhibiting responses for salient immediate rewards) rather than
in stimulus value appraisal. However, inhibition of the right
dlPFC was observed to reduce impulsive DRD in another study
(Cho et al., 2010), but only when participants were exposed to a
significantly higher frequency and shorter duration of magnetic
stimulation than in the study by Figner et al. (2010). Additionally,
a subsequent study using positron emission tomography (PET)
found that inhibition of the right dlPFC reduced impulsive DRD
rates (reducing impulsivity) and disrupted regional cerebral blood
flow (rCBF) in the right dlPFC and right rostral PFC leading to
diminished correlations between DRD rates and rCBF of these
(and other) prefrontal regions (Cho et al., 2012). This suggests
that the neural network underlying impulsive decision making
is disrupted by right dlPFC inhibition. Finally, also using PET
imaging, stimulation of the medial prefrontal cortex has been
found to both reduce DRD rates and reduce the level of synaptic
dopamine in the striatum (Cho et al., 2015). This is clearly amixed
literature and discrepancies among these findings will need to be
reconciled in future studies.
In contrast to TMS, transcranial direct current stimulation
(tDCS) operates by directly passing electrical currents to surface
electrodes placed on the scalp proximal to the region(s) of
interest. One study found no effect of inhibition of left dlPFC and
stimulation of right dlPFC on DRD, but did find that when the
right dlPFC is inhibited and the left dlPFC is stimulated, impulsive
DRD rates increase (Hecht et al., 2013). A second study also found
no effects of left dlPFC inhibition and right dlPFC stimulation
(Kekic et al., 2014). Clearly, this work is at an early stage and
future research should seek to replicate and clarify these findings.
Additional priorities include further exploration of the role of
anode/cathode placement, electrode size, and current intensity on
DRD rates.
Despite early studies showing promise of non-invasive brain
stimulation of the prefrontal cortex in improving impulsive
decision making, it will be important for future studies to clarify
the ideal tool for stimulation (i.e., TMS or tDCS), frequency
and intensity of stimulation, and manipulation of left and right
prefrontal areas. Although research is nascent, TMS appears
to have support both from aforementioned studies and from
interventions for related cognitive functions. For example, a recent
meta-analysis assessed the efficacy of TMS and tDCS of the
dLPFC to improve working memory performance (Brunoni and
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B
A
FIGURE 2 | A framework for considering developing
genetically-informed prevention and treatment. General theoretical
framework for an endophenotype approach to addiction genetics, integrating
endophenotype-specific treatment approaches (Ray et al., 2010) (A). Specific
model of delayed reward discounting (DRD) as an endophenotype of genetic
risk for addiction liability (B). Numbers 1–4 reflect the necessary components
to establish DRD as a viable genetically-influenced prevention target for drug
abuse: (1) a robust relationship between DRD and drug abuse; (2) genetic loci
that are reliably associated with delay discounting; (3) possession of risk
alleles for DRD risk that are responsible for drug abuse risk; (4) efficacious
strategies for reducing impulsive DRD.
Vanderhasselt, 2014), a cognitive function that has been linked to
DRD performance (Bickel et al., 2011; Wesley and Bickel, 2014).
They found that TMS improved response time and accuracy
whereas tDCS improved only response times. Several possible
mechanisms may explain differences in effects found such as
difference in study design, equivalency of “doses,” and better
spatial precision of TMS. In addition to identifying optimal
stimulationmethodology, it will be important for future studies to
explore the potential long term effects of transcranial stimulation
treatment for DRD.
Critique of Delayed Reward Discounting as
a Genetically-Informed Drug Abuse
Prevention Target
In the preceding sections, we reviewed impulsive DRD as a
behavioral characteristic, evidence linking it to genetic influences,
and evidence that it can be significantly ameliorated using a
number of strategies. Here, we consider the assembled findings
and the specific question of whether it has promise for genetically-
informed drug abuse prevention. To do so, we provide a
framework for considering the links that are necessary for coming
to that conclusion (Figure 2). The framework is an extension
of a previous model for integrating alcohol endophenotypes
into treatment development and prospective pharmacotherapies
(Ray et al., 2010). As depicted in Figure 2A, we propose
that endophenotypes can enhance the prospect of genetically-
informed intervention of any kind (prevention or treatment)
by identifying genetically-mediated risk mechanisms that both
enhance the resolution of risk status and serve as intervention
targets. In the first case, endophenotypes (e.g., impulsiveDRD) are
anticipated to ultimately lead tomore reliable identification of risk
alleles via more robust relationships with individual genotypes. In
the second case, the identification of risk status in the context of
a specific mechanism implicitly reveals a candidate intervention
target. In other words, endophenotypes have the potential to
elucidate both the biological causes of the disorder and provide
personalized intervention targets.
Figure 2B lays out the case for DRD, identifying the four
links that necessarily comprise an argument for genetically-
influenced prevention programming. These can be summarized
by the following questions:
(1) Is DRD reliably associated with drug abuse?
(2) Are specific genetic loci reliably associated with DRD?
(3) Are DRD risk alleles also responsible for drug abuse risk?
(4) Are there established strategies for reducing impulsive DRD?
If the empirical support for the links in Figure 2B is reliably
present, the case for a genetically-informed DRD prevention
strategy would be entirely sound. Where those links are less than
robust, however, there remain ambiguities and open questions,
and the rationale becomes more debatable.
In light of the preceding sections, it is clear the latter is the
case for DRD. In the discounting framework, the strongest link
is the first, the association between impulsive DRD and drug
abuse. As discussed, this relationship has been observed in an
array of different samples with an array of different methods,
cross-sectionally and longitudinally. With regard to the genetic
linkages (2 and 3), the literature remains at an early stage. As
noted earlier, although there is relatively strong evidence that
DRD is heritable, there is not a sufficiently strong basis for
defining individuals at higher or lower genetic risk based on
individual genotypes or multi-locus risk scores at this time.
Furthermore, there is very limited evidence that discounting
risk alleles indirectly impact addictive behavior; this has only
been directly demonstrated in one study (Gray and MacKillop,
2014). Similarly, at the level of link 4, intervention research on
DRD remains incipient. Although several methods have been
applied to reducing DRD rates, there is limited consensus on
the ideal approach or combinations of approaches. Furthermore,
many of the methods have not been replicated, examined for
prolonged reductions, or tested in adolescent populations that
would be most appropriate for drug abuse prevention. Similarly,
it is clear is that a number of different strategies are effective
under controlled experimental conditions, but not clear which
strategies (or package of strategies) will successfully translate
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from the laboratory to ‘live’ interventions producing long-term
changes. In sum, a full implementation of an evidence-basedDRD
prevention program for individuals who are genetically at-risk for
more impulsive discounting (and thereby addictive disorders) is
simply not supported by current literature.
Where these links are weakest are the future priorities for the
field. Progress in more definitively identifying genetic correlates
of DRD is essential. Equally, a leading priority going forward
is for pilot research to determine the utility of the discounting
reduction strategies in adolescent samples to identify promising
strategies for prevention contexts. Such studies would be well-
suited to focus on proximal outcomes, most obviously DRD
itself, drug-related motivation, and short-term substance abuse
outcomes. The basis for presuming downstream positive effects of
reducing DRD, of reorienting an individual away from immediate
impulses and toward making more future oriented decisions, is
a logical step forward. Developing efficacious interventions holds
wide implications, not only for addictive disorders, but also more
broadly on behaviors such as good nutrition, financial planning,
and health maintenance behaviors that impact wide swaths of the
general public (Howlett et al., 2008; Bradford, 2010; Epstein et al.,
2010).
An important step in the future will be to identify standardized
norms for DRD performance. As discounting is typically only
assessed in research contexts, there is currently no basis for
determining who should be targeted as a result of their
DRD performance. In order to provide secondary prevention
programming, it is necessary who is and who is not at-risk. The
absence of normative data is a prosaic but nonetheless significant
impediment to progress in this area.
The final point worthy of discussion is whether targeting
discounting based on genetic profiles is a worthwhile undertaking
more broadly. Certainly, from the perspective of personalized
medicine, optimization of any approach using idiographic data
(genetic or otherwise) is desirable. However, given the small
and inconsistent relationships between risk alleles and impulsive
DRD, as well as the extra step involved in genotyping individuals,
amore feasible alternative would be using standardized normative
data for risk identification rather than genetic risk profiles. In
addition, it is also notable that psychosocial factors, such as
early life stress, have also been associated with more impulsive
discounting (e.g., Lovallo et al., 2013) and may be useful for risk
identification. In other words, at the current time, there is a much
stronger rationale for an efficacious DRD prevention program
to be deployed for individuals who are in high-risk groups or
exhibit DRD rates that significantly deviate from standardized
norms than based on genotype. Alternatively, among young
adults, the misuse of alcohol, tobacco, and other drugs is so
prevalent, indeed almost normative in the case of alcohol, and
the links between DRD and diverse forms of externalizing
behavior are so robust, that primary prevention (i.e., universal)
may be a more appropriate strategy. Intervention matching and
secondary prevention are typically assumed to be desirable to
maximize impact and efficiency, but, in this case, if an efficacious
multi-component impulsive DRD prevention program can be
developed, it will be of relevance to the large majority of young
adults.
Conclusion
The goal of this review was to evaluate the viability of DRD
as a target for addictive disorders from the perspective of
genetically-informed drug abuse prevention. A large body of
research links impulsive DRD to drug abuse and supports
the hypothesis that DRD is an endophenotype for addictive
disorders. Additionally, current findings suggest that there are
multiple promising methods—behavioral, pharmacological, and
neuromodulatory—for acutely reducing DRD. However, the
evidence for long-term changes and subsequent salutary health
benefits is scant and no studies have directly assessed preventive
interventions for impulsive DRD. Although significant gaps in
knowledge remain and the wisdom of the long-term goal of
genetically-informed drug abuse prevention viaDRD is debatable,
the current state of the science nonetheless suggests a more
cautious conclusion, that impulsive DRD is more generally a
promising target for drug abuse prevention and specific empirical
investigations in this area are warranted.
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